Get access

Zonula occludens toxin increases the permeability of molecular weight markers and chemotherapeutic agents across the bovine brain microvessel endothelial cells

Authors

  • Chetan S. Karyekar,

    1. Pharmacokinetics Biopharmaceutics Laboratory, Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, 100 Penn Street, Baltimore, Maryland 21201
    Search for more papers by this author
  • Alessio Fasano,

    1. Center for Vaccine Development, School of Medicine, University of Maryland, Baltimore, Maryland 21201
    Search for more papers by this author
  • Sangeeta Raje,

    1. Pharmacokinetics Biopharmaceutics Laboratory, Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, 100 Penn Street, Baltimore, Maryland 21201
    Search for more papers by this author
  • Ruliang Lu,

    1. Center for Vaccine Development, School of Medicine, University of Maryland, Baltimore, Maryland 21201
    Search for more papers by this author
  • Thomas C. Dowling,

    1. Pharmacokinetics Biopharmaceutics Laboratory, Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, 100 Penn Street, Baltimore, Maryland 21201
    Search for more papers by this author
  • Natalie D. Eddington

    Corresponding author
    1. Pharmacokinetics Biopharmaceutics Laboratory, Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, 100 Penn Street, Baltimore, Maryland 21201
    • Pharmacokinetics Biopharmaceutics Laboratory, Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, 100 Penn Street, Baltimore, Maryland 21201. Telephone: 410-706-6710; Fax: 410-706-6580
    Search for more papers by this author

Abstract

The purpose of this study was to examine the ability of Zonula occludens toxin (Zot) to reversibly open tight junctions in bovine brain microvessel endothelial cells (BBMECs) to enhance drug delivery via the paracellular pathway. Transport across BBMEC monolayers was examined for molecular weight markers and chemotherapeutic agents ([14C]sucrose, [14C]inulin, [3H]propranolol, [3H]doxorubicin, and [14C]paclitaxel) with Zot (0.0–4.0 μg/mL). TEER of monolayers was measured to assess effect and reversibility of Zot. Cell viability of BBMEC in the presence of Zot was assessed by trypan blue exclusion staining. Apparent permeability (Papp), enhancement ratio (R), and percent increase in transport determined were statistically compared by ANOVA. A significant increase (p < 0.05) in Papp was observed for the transport of [14C]sucrose, [14C]inulin, [3H]doxorubicin, and [14C]paclitaxel at a 4.0 μg/mL concentration of Zot. A significant concentration-dependent decrease in TEER was observed on treatment with Zot with rapid reversal to baseline after removal. Zot (4 μ/ml) was found to be nontoxic to the BBMECs after 2 hours incubation. In conclusion, Zot increased paracellular transport across the BBMEC in a reversible, concentration-dependent manner. Modulation of paracellular transport with Zot may be used to increase the brain permeability of potent central nervous system-active drugs, including anticancer agents. © 2003 Wiley-Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 92:414–423, 2003

Ancillary